Prognostic impact of large cribriform architecture and intraductal carcinoma of the prostate in diagnostic biopsies of mCSPC receiving ARPI-based therapy [0.03%]
大筛状结构和导管内癌的预后影响:基于ARPI治疗的mCSPC的诊断活检的疗效分析
Shun Sato,Fumihiko Urabe,Yu Imai et al.
Shun Sato et al.
Background: A cribriform architecture and intraductal carcinoma of the prostate (IDC-P) are recognized as aggressive histopathological features in prostate cancer. However, their prognostic significance in metastatic cast...
Developing quality indicators for supportive care in cancer treatment: a modified Delphi method [0.03%]
开发癌症治疗支持性护理质量指标:一种改良德尔菲法
Ayako Okuyama,Chihiro Ishii,Sadamoto Zenda
Ayako Okuyama
Background: Quality indicators for supportive cancer care remain unclear. In this study, we aimed to clarify quality indicators for supportive care addressing side effects experienced by patients undergoing treatment from...
Cellular plasticity of cancer: roles of biomolecular condensates and ecDNA [0.03%]
癌症的细胞 Plasticity:生物分子凝聚物和生态 DNA的作用
Yohei Sugimoto,Yihao Zhang,Takeru Kachi et al.
Yohei Sugimoto et al.
Cancer is characterized not only by malignant transformation driven by genomic alterations but also by remarkable cellular plasticity that enables adaptation to environmental and therapeutic stress. Cancer cell plasticity frequently involve...
Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy' [0.03%]
作者对“关于达尔鲁替胺三联疗法期间发热性中性粒细胞减少风险及 primary G-CSF 预防的贝叶斯解读”的回复
Taizo Uchimoto,Kensuke Hirosuna,Heima Niigawa et al.
Taizo Uchimoto et al.
Comparison of patient characteristics and end-of-life treatments among cancer descendants between designated cancer care hospitals and non-designated hospitals using the national claims database in Japan [0.03%]
利用日本国家索赔数据库比较指定癌症治疗医院与非指定医院的癌症患者的特点及生命末期治疗方法研究
Mitsunori Miyashita,Kazuki Sato,Yoko Nakazawa et al.
Mitsunori Miyashita et al.
Objective: To compare patient characteristics and end-of-life treatment between designated cancer care hospitals and non-designated hospitals, focusing on non-designated hospitals. ...
Multiple enteric fistulas in primary small-intestinal diffuse large B-cell lymphoma [0.03%]
原发性小肠弥漫大B细胞淋巴瘤的多发肠瘘
Taichiro Tokura,Reina Saga,Hiroko Hidai et al.
Taichiro Tokura et al.
Global evidence and clinical implications of spontaneous tumor lysis syndrome in older adults with solid tumors: a systematic review of reported cases [0.03%]
老年人实体瘤自发性肿瘤溶解综合征的全球证据及其临床意义:既往报道病例系统的系统综述
Samuel M Pettit,Na Liu
Samuel M Pettit
Introduction: Spontaneous tumor lysis syndrome (STLS) is rare in solid tumors but highly lethal. Older adults may be especially vulnerable due to comorbidity and homeostenosis. Our objective was to synthesize reported cas...
TP53 mutation landscape and patient survival in oral squamous cell carcinoma [0.03%]
口腔鳞状细胞癌中TP53突变图谱与患者生存率的关系
Mebae Ichikawa,Yusuke Kondo,Joaquim Carreras et al.
Mebae Ichikawa et al.
Introduction: TP53 mutations play a central role in the carcinogenesis of oral squamous cell carcinoma (OSCC). However, due to the diversity of variant patterns of TP53 genetic alterations, the clinical significance of TP...
Bayesian interpretation of febrile neutropenia risk and primary granulocyte colony-stimulating factor prophylaxis during darolutamide triplet therapy [0.03%]
达尔olutamide三联疗法发热性中性粒细胞减少风险的贝叶斯解释及主要粒细胞集落刺激因子预防作用
Hiroshi Fukushima,Soichiro Yoshida,Akihiro Hirakawa et al.
Hiroshi Fukushima et al.
Hypofractionated radiotherapy across cancer sites: a narrative review of evidence and implementation [0.03%]
低剂量分段放射治疗的证据和实施现状:综述
Masahiro Inada,Takuya Uehara,Yukinori Matsuo
Masahiro Inada
Hypofractionated radiotherapy (HFRT), which delivers higher doses per fraction in fewer treatment sessions, represents a practical form of de-escalation in radiation by shortening overall treatment time and reducing patient burden. This nar...